Cargando…

Lung Ventilation/Perfusion Scintigraphy for the Screening of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Which Criteria to Use?

OBJECTIVE: The diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH) is a major challenge as it is a curable cause of pulmonary hypertension (PH). Ventilation/Perfusion (V/Q) lung scintigraphy is the imaging modality of choice for the screening of CTEPH. However, there is no consensus o...

Descripción completa

Detalles Bibliográficos
Autores principales: Le Pennec, Romain, Tromeur, Cécile, Orione, Charles, Robin, Philippe, Le Mao, Raphaël, De Moreuil, Claire, Jevnikar, Mitja, Hoffman, Clément, Savale, Laurent, Couturaud, Francis, Sitbon, Olivier, Montani, David, Jaïs, Xavier, Le Gal, Grégoire, Salaün, Pierre Yves, Humbert, Marc, Le Roux, Pierre Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936142/
https://www.ncbi.nlm.nih.gov/pubmed/35321469
http://dx.doi.org/10.3389/fmed.2022.851935
_version_ 1784672161957412864
author Le Pennec, Romain
Tromeur, Cécile
Orione, Charles
Robin, Philippe
Le Mao, Raphaël
De Moreuil, Claire
Jevnikar, Mitja
Hoffman, Clément
Savale, Laurent
Couturaud, Francis
Sitbon, Olivier
Montani, David
Jaïs, Xavier
Le Gal, Grégoire
Salaün, Pierre Yves
Humbert, Marc
Le Roux, Pierre Yves
author_facet Le Pennec, Romain
Tromeur, Cécile
Orione, Charles
Robin, Philippe
Le Mao, Raphaël
De Moreuil, Claire
Jevnikar, Mitja
Hoffman, Clément
Savale, Laurent
Couturaud, Francis
Sitbon, Olivier
Montani, David
Jaïs, Xavier
Le Gal, Grégoire
Salaün, Pierre Yves
Humbert, Marc
Le Roux, Pierre Yves
author_sort Le Pennec, Romain
collection PubMed
description OBJECTIVE: The diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH) is a major challenge as it is a curable cause of pulmonary hypertension (PH). Ventilation/Perfusion (V/Q) lung scintigraphy is the imaging modality of choice for the screening of CTEPH. However, there is no consensus on the criteria to use for interpretation. The aim of this study was to assess the accuracy of various interpretation criteria of planar V/Q scintigraphy for the screening of CTEPH in patients with PH. METHODS: The eligible study population consisted of consecutive patients with newly diagnosed PH in the Brest University Hospital, France. Final diagnosis (CTEPH or non-CTEPH) was established in a referential center on the management of PH, based on the ESC/ERS guidelines and a minimum follow-up of 3 years. A retrospective central review of planar V/Q scintigraphy was performed by three nuclear physicians blinded to clinical findings and to final diagnosis. The number, extent (sub-segmental or segmental) and type (matched or mismatched) of perfusion defects were reported. Sensitivity and specificity were evaluated for various criteria based on the number of mismatched perfusion defects and the number of perfusion defects (regardless of ventilation). Receiver operating characteristic (ROC) curves were generated and areas under the curve (AUC) were calculated for both. RESULTS: A total of 226 patients with newly diagnosed PH were analyzed. Fifty six (24.8%) were diagnosed with CTEPH while 170 patients (75.2%) were diagnosed with non-CTEPH. The optimal threshold was 2.5 segmental mismatched perfusion defects, providing a sensitivity of 100 % (95% CI 93.6–100%) and a specificity of 94.7% (95%CI 90.3–97.2%). Lower diagnostic cut-offs of mismatched perfusion defects provided similar sensitivity but lower specificity. Ninety five percent of patients with CTEPH had more than 4 segmental mismatched defects. An interpretation only based on perfusion provided similar sensitivity but a specificity of 81.8% (95%CI 75.3–86.9%). CONCLUSION: Our study confirmed the high diagnostic performance of planar V/Q scintigraphy for the screening of CTEPH in patients with PH. The optimal diagnostic cut-off for interpretation was 2.5 segmental mismatched perfusion defects. An interpretation only based on perfusion defects provided similar sensitivity but lower specificity.
format Online
Article
Text
id pubmed-8936142
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89361422022-03-22 Lung Ventilation/Perfusion Scintigraphy for the Screening of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Which Criteria to Use? Le Pennec, Romain Tromeur, Cécile Orione, Charles Robin, Philippe Le Mao, Raphaël De Moreuil, Claire Jevnikar, Mitja Hoffman, Clément Savale, Laurent Couturaud, Francis Sitbon, Olivier Montani, David Jaïs, Xavier Le Gal, Grégoire Salaün, Pierre Yves Humbert, Marc Le Roux, Pierre Yves Front Med (Lausanne) Medicine OBJECTIVE: The diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH) is a major challenge as it is a curable cause of pulmonary hypertension (PH). Ventilation/Perfusion (V/Q) lung scintigraphy is the imaging modality of choice for the screening of CTEPH. However, there is no consensus on the criteria to use for interpretation. The aim of this study was to assess the accuracy of various interpretation criteria of planar V/Q scintigraphy for the screening of CTEPH in patients with PH. METHODS: The eligible study population consisted of consecutive patients with newly diagnosed PH in the Brest University Hospital, France. Final diagnosis (CTEPH or non-CTEPH) was established in a referential center on the management of PH, based on the ESC/ERS guidelines and a minimum follow-up of 3 years. A retrospective central review of planar V/Q scintigraphy was performed by three nuclear physicians blinded to clinical findings and to final diagnosis. The number, extent (sub-segmental or segmental) and type (matched or mismatched) of perfusion defects were reported. Sensitivity and specificity were evaluated for various criteria based on the number of mismatched perfusion defects and the number of perfusion defects (regardless of ventilation). Receiver operating characteristic (ROC) curves were generated and areas under the curve (AUC) were calculated for both. RESULTS: A total of 226 patients with newly diagnosed PH were analyzed. Fifty six (24.8%) were diagnosed with CTEPH while 170 patients (75.2%) were diagnosed with non-CTEPH. The optimal threshold was 2.5 segmental mismatched perfusion defects, providing a sensitivity of 100 % (95% CI 93.6–100%) and a specificity of 94.7% (95%CI 90.3–97.2%). Lower diagnostic cut-offs of mismatched perfusion defects provided similar sensitivity but lower specificity. Ninety five percent of patients with CTEPH had more than 4 segmental mismatched defects. An interpretation only based on perfusion provided similar sensitivity but a specificity of 81.8% (95%CI 75.3–86.9%). CONCLUSION: Our study confirmed the high diagnostic performance of planar V/Q scintigraphy for the screening of CTEPH in patients with PH. The optimal diagnostic cut-off for interpretation was 2.5 segmental mismatched perfusion defects. An interpretation only based on perfusion defects provided similar sensitivity but lower specificity. Frontiers Media S.A. 2022-03-07 /pmc/articles/PMC8936142/ /pubmed/35321469 http://dx.doi.org/10.3389/fmed.2022.851935 Text en Copyright © 2022 Le Pennec, Tromeur, Orione, Robin, Le Mao, De Moreuil, Jevnikar, Hoffman, Savale, Couturaud, Sitbon, Montani, Jaïs, Le Gal, Salaün, Humbert and Le Roux. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Le Pennec, Romain
Tromeur, Cécile
Orione, Charles
Robin, Philippe
Le Mao, Raphaël
De Moreuil, Claire
Jevnikar, Mitja
Hoffman, Clément
Savale, Laurent
Couturaud, Francis
Sitbon, Olivier
Montani, David
Jaïs, Xavier
Le Gal, Grégoire
Salaün, Pierre Yves
Humbert, Marc
Le Roux, Pierre Yves
Lung Ventilation/Perfusion Scintigraphy for the Screening of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Which Criteria to Use?
title Lung Ventilation/Perfusion Scintigraphy for the Screening of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Which Criteria to Use?
title_full Lung Ventilation/Perfusion Scintigraphy for the Screening of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Which Criteria to Use?
title_fullStr Lung Ventilation/Perfusion Scintigraphy for the Screening of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Which Criteria to Use?
title_full_unstemmed Lung Ventilation/Perfusion Scintigraphy for the Screening of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Which Criteria to Use?
title_short Lung Ventilation/Perfusion Scintigraphy for the Screening of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Which Criteria to Use?
title_sort lung ventilation/perfusion scintigraphy for the screening of chronic thromboembolic pulmonary hypertension (cteph): which criteria to use?
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936142/
https://www.ncbi.nlm.nih.gov/pubmed/35321469
http://dx.doi.org/10.3389/fmed.2022.851935
work_keys_str_mv AT lepennecromain lungventilationperfusionscintigraphyforthescreeningofchronicthromboembolicpulmonaryhypertensionctephwhichcriteriatouse
AT tromeurcecile lungventilationperfusionscintigraphyforthescreeningofchronicthromboembolicpulmonaryhypertensionctephwhichcriteriatouse
AT orionecharles lungventilationperfusionscintigraphyforthescreeningofchronicthromboembolicpulmonaryhypertensionctephwhichcriteriatouse
AT robinphilippe lungventilationperfusionscintigraphyforthescreeningofchronicthromboembolicpulmonaryhypertensionctephwhichcriteriatouse
AT lemaoraphael lungventilationperfusionscintigraphyforthescreeningofchronicthromboembolicpulmonaryhypertensionctephwhichcriteriatouse
AT demoreuilclaire lungventilationperfusionscintigraphyforthescreeningofchronicthromboembolicpulmonaryhypertensionctephwhichcriteriatouse
AT jevnikarmitja lungventilationperfusionscintigraphyforthescreeningofchronicthromboembolicpulmonaryhypertensionctephwhichcriteriatouse
AT hoffmanclement lungventilationperfusionscintigraphyforthescreeningofchronicthromboembolicpulmonaryhypertensionctephwhichcriteriatouse
AT savalelaurent lungventilationperfusionscintigraphyforthescreeningofchronicthromboembolicpulmonaryhypertensionctephwhichcriteriatouse
AT couturaudfrancis lungventilationperfusionscintigraphyforthescreeningofchronicthromboembolicpulmonaryhypertensionctephwhichcriteriatouse
AT sitbonolivier lungventilationperfusionscintigraphyforthescreeningofchronicthromboembolicpulmonaryhypertensionctephwhichcriteriatouse
AT montanidavid lungventilationperfusionscintigraphyforthescreeningofchronicthromboembolicpulmonaryhypertensionctephwhichcriteriatouse
AT jaisxavier lungventilationperfusionscintigraphyforthescreeningofchronicthromboembolicpulmonaryhypertensionctephwhichcriteriatouse
AT legalgregoire lungventilationperfusionscintigraphyforthescreeningofchronicthromboembolicpulmonaryhypertensionctephwhichcriteriatouse
AT salaunpierreyves lungventilationperfusionscintigraphyforthescreeningofchronicthromboembolicpulmonaryhypertensionctephwhichcriteriatouse
AT humbertmarc lungventilationperfusionscintigraphyforthescreeningofchronicthromboembolicpulmonaryhypertensionctephwhichcriteriatouse
AT lerouxpierreyves lungventilationperfusionscintigraphyforthescreeningofchronicthromboembolicpulmonaryhypertensionctephwhichcriteriatouse